216 related articles for article (PubMed ID: 16635070)
21. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP
Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990
[TBL] [Abstract][Full Text] [Related]
22. Platelet storage for transfusion.
Murphy S
Beitr Infusionther Klin Ernahr; 1986; 15():93-106. PubMed ID: 3753417
[TBL] [Abstract][Full Text] [Related]
23. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.
Dijkstra-Tiekstra MJ; Pietersz RN; Huijgens PC
Vox Sang; 2004 Nov; 87(4):257-63. PubMed ID: 15585021
[TBL] [Abstract][Full Text] [Related]
24. Platelet storage at 22 degrees C for transfusion: interrelationship of platelet density and size, medium pH, and viability after in vivo infusion.
Holme S; Murphy S
J Lab Clin Med; 1983 Jan; 101(1):161-74. PubMed ID: 6848613
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the correlation of platelet morphology with in vivo recovery and survival.
Mintz PD; Anderson G; Avery N; Clark P; Bonner RF
Transfusion; 2005 Aug; 45(2 Suppl):72S-80S. PubMed ID: 16086792
[TBL] [Abstract][Full Text] [Related]
26. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
27. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
28. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
Cardo LJ; Rentas FJ; Ketchum L; Salata J; Harman R; Melvin W; Weina PJ; Mendez J; Reddy H; Goodrich R
Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
[TBL] [Abstract][Full Text] [Related]
29. Platelet function in variable platelet split products intended for neonatal transfusion.
Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
[TBL] [Abstract][Full Text] [Related]
30. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G
Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398
[TBL] [Abstract][Full Text] [Related]
32. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative.
Dumont LJ; AuBuchon JP; Gulliksson H; Slichter SJ; Elfath MD; Holme S; Murphy JR; Rose LE; Popovsky MA; Murphy S
Transfusion; 2006 Aug; 46(8):1300-5. PubMed ID: 16934063
[TBL] [Abstract][Full Text] [Related]
33. In vitro platelet quality in storage containers used for pediatric transfusions.
Weiss S; Scammell K; Levin E; Culibrk B; Zolfaghari S; Gyöngyössy-Issa MI; Acker JP
Transfusion; 2012 Aug; 52(8):1703-14. PubMed ID: 22257224
[TBL] [Abstract][Full Text] [Related]
34. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation.
Javela K; Eronen J; Sarna S; Kekomäki R
Transfusion; 2005 Sep; 45(9):1504-11. PubMed ID: 16131384
[TBL] [Abstract][Full Text] [Related]
35. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
[TBL] [Abstract][Full Text] [Related]
36. The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.
Reikvam H; Marschner S; Apelseth TO; Goodrich R; Hervig T
Blood Transfus; 2010 Jul; 8(3):186-92. PubMed ID: 20671879
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
Seghatchian J; Tolksdorf F
Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
[TBL] [Abstract][Full Text] [Related]
38. Extended storage of platelets in SSP platelet additive solution.
Hornsey VS; McColl K; Drummond O; McMillan L; Morrison A; Morrison L; MacGregor IR; Prowse CV
Vox Sang; 2006 Jul; 91(1):41-6. PubMed ID: 16756600
[TBL] [Abstract][Full Text] [Related]
39. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
Picker SM; Schneider V; Gathof BS
Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
[TBL] [Abstract][Full Text] [Related]
40. Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets.
Valeri CR; MacGregor H; Barnard MR; Summaria L; Michelson AD; Ragno G
Vox Sang; 2005 Feb; 88(2):122-9. PubMed ID: 15720610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
